Invenomic Capital Management’s Liberty Latin America Class C LILAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-408,956
Closed -$2.29M 154
2022
Q3
$2.29M Sell
408,956
-1,438,985
-78% -$9.26M 0.2% 113
2022
Q2
$13.1M Buy
1,847,941
+169,476
+10% +$1.41M 0.93% 32
2022
Q1
$14.6M Buy
+1,678,465
New +$16M 1.56% 11

Other funds holding LILAK

Invenomic Capital Management's LILAK Position: Q4 2022 in Review

Invenomic Capital Management sold out of Liberty Latin America Class C (LILAK) in Q4 2022, closing a stake of 408,956 shares — an estimated $2.29M sold.

Invenomic Capital Management first reported a position in LILAK in Q1 2022 and held it in 3 quarters. The position peaked at $14.6M in Q1 2022. 208 funds tracked by Wall St. Rank hold LILAK as of Q4 2022.

  • Invenomic Capital Management reported no remaining Liberty Latin America Class C position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 408,956 Liberty Latin America Class C shares in Q4 2022, an estimated $2.29M.
  • Invenomic Capital Management first reported a position in Liberty Latin America Class C in Q1 2022 and held it in 3 quarters.
  • Invenomic Capital Management's Liberty Latin America Class C position peaked at $14.6M in Q1 2022.
  • 208 funds tracked by Wall St. Rank held Liberty Latin America Class C as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.